Zobrazeno 51 - 60
of 899
pro vyhledávání: '"Nicolaus Kröger"'
Autor:
Nicolaus Kröger, Laurent Garderet
Publikováno v:
Hemato, Vol 3, Iss 1, Pp 1-2 (2021)
Immunotherapy has become a major pillar in the treatment of multiple myeloma [...]
Externí odkaz:
https://doaj.org/article/96359272e8294187afcf53fbdbf77a5e
Autor:
Radwan Massoud, Nico Gagelmann, Ulrike Fritzsche-Friedland, Gaby Zeck, Silke Heidenreich, Christine Wolschke, Francis Ayuk, Maximilian Christopeit, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 107, Iss 4 (2021)
Anti-T-cell lymphocyte globulin (ATLG) and posttransplant cyclophosphamide (PTCy) are now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic stem cell transplantation. Data comparing immune reconstitution (IR) between
Externí odkaz:
https://doaj.org/article/974a841e64fc4c5c8a28d5d27839a385
Autor:
Benedetto Bruno, Ralph Wäsch, Monika Engelhardt, Francesca Gay, Luisa Giaccone, Mattia D’Agostino, Luis-Gerardo Rodríguez-Lobato, Sophia Danhof, Nico Gagelmann, Nicolaus Kröger, Rakesh Popat, Niels W.C.J. van de Donk, Evangelos Terpos, Meletios A. Dimopoulos, Pieter Sonneveld, Hermann Einsele, Mario Boccadoro
Publikováno v:
Haematologica, Vol 106, Iss 8 (2021)
Chimeric antigen receptor (CAR) T cells (CAR-T) have dramatically changed the treatment landscape of B-cell malignancies, providing a potential cure for relapsed/refractory patients. Long-term responses in patients with acute lymphoblastic leukemia a
Externí odkaz:
https://doaj.org/article/dfc7ce3c93f249d9a7371b573a30ca31
Autor:
Nico Gagelmann, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 106, Iss 7 (2021)
Allogeneic hematopoietic stem-cell transplantation is a potentially curative therapy for various hematologic diseases. An essential component of this procedure is the pre-transplant conditioning regimen, which should facilitate engraftment and reduce
Externí odkaz:
https://doaj.org/article/d9879efa3c9e4160a86c198b59ab71d5
Autor:
Nico Gagelmann, Christine Wolschke, Evgeny Klyuchnikov, Maximilian Christopeit, Francis Ayuk, Nicolaus Kröger
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
This analysis aimed to systematically review and synthesize the existing evidence regarding the outcome of tyrosine kinase inhibitor (TKI) maintenance therapy after allogeneic stem-cell transplantation for patients with FLT3-ITD-mutated acute myeloid
Externí odkaz:
https://doaj.org/article/7cf0927a546b49be8b73bd5cdd8cac21
Autor:
Francesco Saraceni, Myriam Labopin, Arne Brecht, Nicolaus Kröger, Matthias Eder, Johanna Tischer, Hélène Labussière-Wallet, Hermann Einsele, Dietrich Beelen, Donald Bunjes, Dietger Niederwieser, Tilmann Bochtler, Bipin N. Savani, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-10 (2019)
Abstract Background Limited data is available to guide the choice of the conditioning regimen for patients with acute myeloid leukemia (AML) undergoing transplant with persistent disease. Methods We retrospectively compared outcome of fludarabine-tre
Externí odkaz:
https://doaj.org/article/1953bf4f9ad946aaad8280d944ff90cf
Autor:
Adrin Dadkhah, Sebastian Georg Wicha, Nicolaus Kröger, Alexander Müller, Christoph Pfaffendorf, Maria Riedner, Anita Badbaran, Boris Fehse, Claudia Langebrake
Publikováno v:
Pharmaceutics, Vol 14, Iss 6, p 1145 (2022)
For patients with myelofibrosis, allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative treatment to date. Busulfan-based conditioning regimens are commonly used, although high inter-individual variability (IIV) in b
Externí odkaz:
https://doaj.org/article/44b5b7decaca406883d6723d53ed4764
Autor:
Daphne Mytilineos, Chrysanthi Tsamadou, Christine Neuchel, Uwe Platzbecker, Donald Bunjes, Natalie Schub, Eva Wagner-Drouet, Gerald Wulf, Nicolaus Kröger, Niels Murawski, Hermann Einsele, Kerstin Schaefer-Eckart, Sebastian Freitag, Jochen Casper, Martin Kaufmann, Mareike Dürholt, Bernd Hertenstein, Stefan Klein, Mark Ringhoffer, Carlheinz R. Mueller, Sandra Frank, Hubert Schrezenmeier, Daniel Fuerst, Joannis Mytilineos
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
T-cell epitope matching according to the TCE3 algorithm classifies HLA-DPB1 mismatches in permissive and non-permissive. This classification has been shown to be predictive for mortality and acute GvHD (aGvHD) events in large international cohorts. W
Externí odkaz:
https://doaj.org/article/ee8dbb750c2243f7b3fbc668a0b83d84
Autor:
Johannes Schetelig, Henning Baldauf, Linda Koster, Michelle Kuxhausen, Falk Heidenreich, Liesbeth C. de Wreede, Stephen Spellman, Michel van Gelder, Benedetto Bruno, Francesco Onida, Vinzenz Lange, Carolin Massalski, Victoria Potter, Per Ljungman, Nicolaas Schaap, Patrick Hayden, Stephanie J. Lee, Nicolaus Kröger, Kathy Hsu, Alexander H. Schmidt, Ibrahim Yakoub-Agha, Marie Robin
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Results from registry studies suggest that harnessing Natural Killer (NK) cell reactivity mediated through Killer cell Immunoglobulin-like Receptors (KIR) could reduce the risk of relapse after allogeneic Hematopoietic Cell Transplantation (HCT). Sev
Externí odkaz:
https://doaj.org/article/693c028224f942ae8e114564d060c6a0
Autor:
Andrzej Frankiewicz, Christophe Peczynski, Sebastian Giebel, Alenca Harrington, Gerard Socié, Dietger Niederwieser, Christoph Scheid, Martin Bornhäuser, Nicolaus Kröger, Ahmet Elmaagacli, Boris Afanasyev, Peter Dreger, Claudia Rössig, Didier Blaise, Christian Kratz, Ibrahim Yakoub-Agha, Bernhard Kremens, Charlotte Marie Niemeyer, Gerald Wulf, Igor Blau, Olaf Penack, Hildegard Greinix, Grzegorz W. Basak
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Acute graft-vs.-host disease (aGvHD) is one of the most frequent causes of transplant-related mortality (TRM) after allogeneic hematopoietic cell transplantation (alloHCT). Its treatment is complex and costly. The aim of this study was to retrospecti
Externí odkaz:
https://doaj.org/article/322ecd6434084545b3444a71e3918c42